Kodak to produce active ingredients in shortage for generic drugs

Jul 28, 2020 - 02:56 PM
COVID19 Web Sized

The U.S. International Development Finance Corporation today signed a letter of interest to provide a $765 million loan to Eastman Kodak Company to repurpose and expand its facilities in Rochester, N.Y., and St. Paul, Minn., to produce active pharmaceutical ingredients in short supply.

Once the facilities are fully operational, the company expects to produce up to 25% of the active pharmaceutical ingredients used in non-biologic, non-antibacterial generic pharmaceuticals.

The agency recently requested private-sector proposals for financing to support domestic production or distribution of pharmaceuticals, vaccines, personal protective equipment and medical testing supplies under the Defense Production Act, as authorized by a May executive order in response to the COVID-19 emergency.

Related News Articles

Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
CDC data shows rise in flu, COVID-19 cases across states 
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…